References
- GreydanusDEPrattHDPatelDRAttention deficit hyperactivity disorder across the lifespanDis A Month200753265132
- MayesRBagwellCErkulwaterJMedicating Children: ADHD and Pediatric Mental HealthCambridge, MassachusettsHarvard University Press2009
- BarkleyRAAttention-deficit/hyperactivity disorderSci Am199866719725940
- SoileauEJMedications with adolescents with attention-deficit/ hyperactivity disorderAdolesc Med200819254267
- WolraichMLWibbelsmanCJBrownTEAttention deficit/ hyperactivity disorder among adolescentsPediatrics2005115173415930238
- StauferWBGreydanusDEAttention-deficit/hyperactivity disorder: Psychopharmacology for college studentsPediatric Clin North Am2005527184
- BiedermanJFaraoneSCAttention-deficit hyperactivity disorderLancet200536723724816023516
- RobinASchubinerHColemanWLADHD/learning disordersAdolesc Med2008192209356
- EpsteinJNLangbergJMLichtensteinPKCommunity-wide intervention to improve the attention-deficit/hyperactivity disorder assessment and treatment practices of community physiciansPediatrics2008122192718595982
- MayesRRafalovichASuffer the restless children: the evolution of ADHD and paediatric stimulant use: 1900–1980Hist Psychiatry200718(72 Pt 4):43545718590022
- GreydanusDESloaneMARappleyMDPsychopharmacology of ADHD in adolescentsAdolesc Med20021359962412270803
- GreydanusDEPrattHDSloaneMAAttention-deficit/ hyperactivity disorder in children and adolescents: Interventions for a complex costly clinical conundrumPediatr Clin North Am2003501049109214558681
- HammernessPSurmanCMillerKUpdate on adult ADHDCurr Neurol Neurosci Rep20088849859
- GreydanusDECallesJLPatelDRPediatric and Adolescent PsychopharmacologyCambridge, EnglandCambridge University Press2008
- PierceDDixonCMWigalSBPharmacokinetics of methyl-phenidate transdermal system (MTS): results from a classroom studyJ Child Adolesc Psychopharmacol20081835536418759645
- PatrickKCStraughnABPerkinsJSGonzálezMAEvolution of stimulants to treat ADHD: transdermal methylphenidateHum Psychopharmacol200924111719051222
- GreydanusDEPharmacologic treatment of attention-deficit/ hyperactivity disorderIndian J Pediatrics2005722734
- GreydanusDEPrattHDADHD in children and adolescentsGreydanusDEPatelDRPrattHDBehavioral pediatrics2nd edNew YorkiUniverse Publishers2006
- SilvaRRMunixRPestreichLDexmethylphenidate extended release capsules in children with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry20084719920818176337
- SolantoMVArnstenAFTCastellanosFXThe Neuroscience of stimulant drug action in ADHDSolantoMVArnstenAFTCastellanosFXStimulant drugs and ADHDLondonOxford Univ Press2001355379
- ZitoJMSaferDJdosReisSPsychotropic practice patterns for youth. A 10-year perspectiveArch Pediatr Adolesc Med2003157172512517190
- CoxERHalloranDRHomanSMTrends in the prevalence of chronic medication use in children: 2002–2005Pediatrics2008122e1053e106118977954
- VolkowNDFowlerJSWangGDingYGatleySJMechanism of action of methylphenidate: insights from PET imaging studiesJ Atten Disord20026Suppl 1S31S4312685517
- Tourette’s Syndrome Study GroupTreatment of ADHD in children with tics: a randomized controlled trialNeurology200258452753611865128
- PatelDRGreydanusDENeurological conditions and disability in adolescentsIntl J Disabil Hum Dev200873279282
- JankovicJTourette’s syndromeN Engl J Med20013451184119211642235
- PerrinJMFriedmanRAKnilansTKCardiovascular monitoring and stimulant drugs for attention deficit/hyperactivity disorderPediatrics200812245145318676566
- VetterVLEliaJEricksonCCardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs. A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young, Congenital Cardiac Defects Committee and the Council on Cardiovascular NursingCirculation20081172407242318427125
- FoneKCFNuttDJStimulants: use and abuse in the treatment of attention deficit hyperactivity disorderCurr Opin Pharmacol20055879315661631
- WilensTEGignacMSwezeyACharacteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medicationsJ Am Acad Child Adolesc Psychiatry20064540841416601645
- WilensTEFaraoneSVBiedermanJDoes stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literaturePediatrics200311117918512509574
- GreydanusDEPatelDRThe adolescent and substance abuse: Current conceptsCurr Probl Pediatr Adolesc Health Care2005353789815723035
- BramstedtKACaffeine use by children: quest for enhancementSubst Use Misuse2007421237125117674233
- GehrickeJGLoughlinSEWhalenCKSmoking to self-mediate attentional and emotional dysfunctionNicotine Tob Res20079Suppl 4S523S53618067030
- BradleyCThe behavior of children receiving benzedrineAm J Psychiatry1937577585
- Lisdexafetamine dimesylate (Vyvanse) for ADHDMed Lett2007495859
- LopezFAGinsbergLDArnoldVEffect of lisdexamfetamine dimethylate on parent-rated measures in children aged 6–12 years with attention-deficit hyperactivity disorder: a secondary analysisPost grad Med200812089102
- http:www.fda.gov/medwatch/safety/2005/safety05.htm#Strattera
- SpencerTBiedermanJWilensTEffectiveness and tolerability of atomoxetine in adults with attention-deficit hyperactivity disorderAm J Psychiatry19981556936959585725
- MichelsonDAllenAJBusnerJOnce-daily atomoxetine treatment for children and adolescents with ADHD: A randomized, placebo-controlled studyAm J Psychiatry20021591896190112411225
- Atomoxetine (Strattera) for ADHDMed Lett2003451112
- AllenAJSpencerTJHeiligensteinJHSafety and efficacy of atomoxetine for AHDH in two double-blind, placebo-controlled trialsBiol Psychiatry200149Suppl 832S33S
- BiedermannJMelmedRDPatelAGuanfacine extended release for Pediatric Attention deficit/hyperactivity disorderPediatrics2008121e73e8418166547
- BiedermanJMelmedRDPatelAA randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with ADHDPediatrics2008121e73e8418166547
- VarleyCSudden death of a child treated with imipramineJ Child Adolesc Psychopharmacol20001032132511191693
- VarleyCKSudden death related to selected tricyclic antidepressants in children: Epidemiology, mechanisms and clinical implicationsPaediatr Drugs2001361362711577926
- PliszkaSRGreenhillLLCrismonMLThe Texas Children’s Medication Algorithm Project: Report of the Texas Consensus Conference Panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part IJ Am Acad Child Adolesc Psychiatry20013990891910892234
- DavissWBBuproprion for adolescents with attention-deficit/ hyperactivity disorderJ Am Acad Child Adolesc Psychiatry20014030731411288772
- Wilkes S BupropionDrugs Today20064210671681
- FindlingRLGreenhillLLMcNamaraNKVenlafaxine in the treatment of children and adolescents with attention deficit hyperactivity disorderJ Child Adolesc Psychopharmacol20071743344517822339
- TurnerDCClarkLDowsonJModafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorderBiol Psychiatry2004551031104015121488
- LópezFAADHD: New pharmacologic treatments on the horizonJ Dev Behav Pediatr20062741041617041279
- BiedermanJPliszkaSRModafanil improves symptoms of attention-deficit hyperactivity disorder across subtypes in children and adolescentsJ Pediatr200815239439918280848
- BallonJSFeifelDA systemic review of modafanil: Potential clinical uses and mechanism of actionJ Clin Psychiatr200667554566
- KumarRApproved and investigational uses of modafanil: An evidence-based reviewDrugs2008681803183918729534
- SteinMAMcGoughJJThe pharmacogenomic era: promise for personalizing ADHD therapyChild Adolesc Psychiatry Clin N Amer200817475490
- SwansonJMHechtmanLUsing long-acting stimulants: does it change ADHD treatment outcome?Can Child Adolesc Psychiatr Rev200514Suppl 12319030517
- GreydanusDEMetilfenidato: Ventajas de metifenidato de liberacion immediata sobre las formulaciones de metifenidato de liberacion prolongadaEuromedice200723
- DanyszWCX-516 Cortex PharmaceuticalsCurr Opin Invest Drugs2002310811088
- WeislerRAEmerging drugs for ADHDExpert Opin Emerg Drugs20071242343417874970
- LevinEDNicotinic receptor subtypes and cognitive functionNeurol Biol200253633646
- AdlerLAChuaHCManagement of ADHD in adultsJ Clin Psychiatr200263Suppl 122935
- KonofalEArnuufILecendreauxMMourenMCRopinirole in a child with attention-deficit hyperactivity disorder and restless legs syndromePediatr Neurol20053035035115866437
- FindingRLEvolution of the treatment for attention-deficit hyperactivity disorder in children: a reviewClin Ther20083094295118555941
- KarroumEKonofalEArnuufIRestless legs syndromeRev Neurol200816470172118656214
- FindlingRLShortEJLeskovecTAripiprazole in children with ADHDJ Child Adolesc Psychopharmacol20081834735418759644
- FindlingRLAtypical antipsychotic treatment of disruptive behavior disorders in children and adolescentsJ Clin Psychiatry200869Suppl 491418533763
- TorenPRatnerSWeizmanAReboxetine maintenance treatment in children with ADHD: A long term follow-up studyJ Child Adolesc Psychopharmacol20071780381218315452
- A new long-acting methylphenidate (Concerta)Med Lett2000428081
- Another long-acting methylphenidate (Metadate CD)Med Lett2001438384
- Dexmethylphenidate (Focalin) for ADHDMed Lett2002444546
- PliszkaSAACAP Work Group on Quality IssuesPractice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry20074689492117581453
- HechtmanLGreenfieldBLong-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcomePaediatr Drugs2003578779414658920
- LernerMWigalTLong-term safety of stimulant medications used to treat children with ADHDPediatr Ann200837374518240852
- CallesJLADHD in children and adolescentsGreydanusDEPatelDRPrattHDBehavioral Pediatrics3rd edNew YorkNova Science Publishers2009